US Patent 7226950 Sodium channel modulators
Patent 7226950 was granted and assigned to Theravance on June, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+405 characters)
Article
Patent abstract
The invention provides sodium channel modulating compounds which are useful for treating diseases or conditions associated with sodium channel activity, such as neuropathic pain. The invention also provides pharmaceutical compositions comprising a compound of the present invention, as well as therapeutic methods comprising administering such a compound or salt to a mammal (e.g. a human).
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07226950 Sodium channel modulators US Patent 7226950 Sodium channel modulators
Infobox
Patent Number
0722695000
Patent Number
722695000
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072269500
Date of Patent
June 5, 2007
0Patent Application Number
115000780
Date Filed
August 7, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072269500
Date of Patent
June 5, 2007
0Patent Application Number
115000780
Date Filed
August 7, 2006
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07226950 Sodium channel modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07226950
Date of patent
June 5, 2007
Patent application number
11500078
Date Filed
August 7, 2006
Patent primary examiner
Find more entities like US Patent 7226950 Sodium channel modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
